Vitamin A supplements and mortality related to measles: A randomised clinical trial

236Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

Abstract

One hundred and eighty children admitted with measles were randomly allocated to receive routine treatment alone or with additional large doses of vitamin A (200 000 IU orally immediately and again the next day). Baseline characteristics of the two groups were virtually identical for, age, severity of measles, and vitamin A and general nutritional states. In 91% of the children serum vitamin A concentrations were less than 0·56 μmol/1. Of the 88 subjects given vitamin A supplements, six (7%) died; of the 92 controls, 12 (13%) died (p=0·13). This difference in mortality was most obvious for children aged under 2 years (one death out of 46 children receiving supplements versus seven deaths out of 42 controls; p<0·05) and for cases complicated by croup or laryngotracheobronchitis. Mortality was several times higher in marasmic than in better nourished children, regardless of study allocation (p<0·01). © 1987, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Barclay, A. J. G., Foster, A., & Sommer, A. (1987). Vitamin A supplements and mortality related to measles: A randomised clinical trial. British Medical Journal (Clinical Research Ed.), 294(6567), 294–296. https://doi.org/10.1136/bmj.294.6567.294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free